Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms

British Journal of Pharmacology

Volumn 140, Issue 3, 2003, Pages 507-519

  Beigi, Reza D ^a   Kertesy, Sylvia B ^a   Aquilina, Gretchen ^a   Dubyak, George R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ecto ATPase; Ecto nucleotidase; Inflammation; Inflammatory signaling; oATP; Oxidized ATP; P2; P2X 7; Purinergic; Receptor

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; 2' DEOXY 2 CHLORO N6 METHYLADENOSINE 3',5' BISPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; APYRASE; DIGITONIN; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LUCIFERASE; MRS 2216; OXIDIZED ADENOSINE TRIPHOSPHATE; PURINE P2 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENCY; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; CELL LINE; CELL LINE, TUMOR; CYTOKINES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; OXIDATION-REDUCTION; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 0142184953     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705470     Document Type: Article

References (70)

1. ABBRACCHIO, M.P., BOEYNAEMS, J.M., BARNARD, E.A., BOYER, J.L., KENNEDY, C., MIRAS-PORTUGAL, M.T., KING, B.F., GACHET, C., JACOBSON, K.A., WEISMAN, G.A. & BURNSTOCK, G. (2003). Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci., 24, 52-55.
2. 1 macrophages by adenosine triphosphate. J. Biol. Chem., 274, 36764-36768.
3. BEIGI, R. & DUBYAK, G.R. (2000). Endotoxin activation of macrophages does not induce ATP release and autocrine stimulation of P2 nucleotide receptors. J. Immunol., 165, 7189-7198.
4. +-ATPase active site. Eur. J. Biochem., 194, 413-421.
5. BIANCHI, B.R., LYNCH, K.J., TOUMA, E., NIFORATOS, W., BURGARD, E.C., ALEXANDER, K.M., PARK, H.S., YU, H., METZGER, R., KOWALUK, E., JARVIS, M.F. & VAN BIESEN, T. (1999). Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur. J. Pharmacol., 376, 127-138.
6. BRADLEY, K.K. & BRADLEY, M.E. (2001). Purine nucleoside-dependent inhibition of cellular proliferation in 1321N1 human astrocytoma cells. J. Pharmacol. Exp. Ther., 299, 748-752.
7. CHEN, B.C., CHOU, C.F. & LIN, W.W. (1998). Pyrimidinoceptor-mediated potentiation of inducible nitric-oxide synthase induction in J774 macrophages. Role of intracellular calcium. J. Biol. Chem., 273, 29754-29763.
8. CINES, D.B., POLLAK, E.S., BUCK, C.A., LOSCALZO, J., ZIMMERMAN, G.A., MCEVER, R.P., POBER, J.S., WICK, T.M., KONKLE, B.A., SCHWARTZ, B.S., BARNATHAN, E.S., MCCRAE, K.R., HUG, B.A., SCHMIDT, A.-M. & STERN, D.M. (1998). Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 91, 3527-3561.
9. CLIFFORD, E.E., MARTIN, K.A., DALAL, P., THOMAS, R. & DUBYAK, G.R. (1997). Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5′-nucleotidase in myeloid leukocytes. Am. J. Physiol. Cell Physiol., 273, C973-C987.
10. COLMAN, R.F. (1983). Affinity labeling of purine nucleotide sites in proteins. Ann. Rev. Biochem., 52, 67-91.
11. COMMUNI, D., ROBAYE, B. & BOEYNAEMS, J.-M. (1999). Pharmacological characterization of the human P2Y11 receptor. Br. J. Pharmacol., 128, 1199-1206.
12. i. J. Biol. Chem., 276, 41479-41485.
13. CRAIGHEAD, M.W., MIDDLEHURST, K.M., LEFEUVRE, R., KIMBER, I. & ROTHWELL, N.J. (2001). Oxidised adenosine 5′-triphosphate, a P2X(7) antagonist, is toxic to rat cerebellar granule neurones in vitro. Neurosci. Lett., 311, 77-80.
14. DELL'ANTONIO, G., QUATTRINI, A., DAL CIN, E., FULGENZI, A. & FERRERO, M.E. (2002). Antinociceptive effect of a new P(2Z)/ P2X7 antagonist, oxidized ATP, in arthritic rats. Neurosci. Lett., 327, 87-90.
15. EASTERBROOK-SMITH, S.B., WALLACE, J.C. & KEECH, D.B. (1976). Pyruvate carboxylase: affinity labelling of the magnesium adenosine triphosphate binding site. Eur. J. Biochem., 62, 125-130.
16. ENJYOJI, K., SÉVIGNY, J., LIN, Y., FRENETTE, P.S., CHRISTIE, P.D., SCHULTE, A.M., ESCH II, J., IMAI, M., EDELBERG, J.M., RAYBURN, H., LECH, M., BEELER, D.L., CSIZMADIA, E., WAGNER, D.D., ROBSON, S.C. & ROSENBERG, R.D. (1999). Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat. Med., 5, 1010-1017.
17. EVANS, R.J., LEWIS, C., BUELL, G., VALERA, S., NORTH, R.A. & SURPRENANT, A. (1995). Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol. Pharmacol., 48, 178-183.
18. FERRARI, D., CHIOZZI, P., FALZONI, S., DAL SUSINO, M., MELCHIORRI, L., BARICORDI, O.R. & DI VIRGILIO, F. (1997a). Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol., 159, 1451-1458.
19. FERRARI, D., CHIOZZI, P., FALZONI, S., HANAU, S. & DI VIRGILIO, F. (1997b). Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med., 185, 579-582.
20. FOURNIER, M., LABOUESSE, B. & LABOUESSE, J. (1987). Reaction of tryptophanyl-tRNA synthetase from beef pancreas with periodate-oxidized ATP. Eur. J. Biochem., 167, 533-540.
21. GALVANI, A.P., CRISTIANI, C., CARPINELLI, P., LANDONIO, A. & BERTOLERO, F. (1995). Suramin modulates cellular levels of hepatocyte growth factor receptor by inducing shedding of a soluble form. Biochem. Pharmacol., 50, 959-966.
22. GHOSH, S. & KARIN, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell, 109, S81-S96.
23. GLASS, R., LOESCH, A., BODIN, P. & BURNSTOCK, G. (2002). P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells. Cell. Mol. Life Sci., 59, 870-881.
24. GOEPFERT, C., IMAI, M., BROUARD, S., CSIZMADIA, E., KACZMAREK, E. & ROBSON, S.C. (2000). CD39 modulates endothelial cell activation and apoptosis. Mol. Med., 6, 591-603.
25. GRAHAMES, C.B., MICHEL, A.D., CHESSELL, I.P. & HUMPHREY, P.P. (1999). Pharmacological characterization of ATP-and LPS-induced IL-1beta release in human monocytes. Br. J. Pharmacol., 127, 1915-1921.
26. GRAZIOLI, L., ALZANI, R., CIOMEI, M., MARIANI, M., RESTIVO, A., COZZI, E. & MARCUCCI, F. (1992). Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor alpha. Int. J. Immunopharmacol., 14, 637-642.
27. GU, B., BENDALL, L.J. & WILEY, J.S. (1998). Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood, 92, 946-951.
28. 7 nucleotide receptor in monocytes, macrophages, and HEK293 fibroblasts. Am. J. Physiol. Cell Physiol., 285, C286-C299.
29. HARPER, N., FARROW, S.N., KAPTEIN, A., COHEN, G.M. & MACFARLANE, M. (2001). Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-kappa B activation by inhibition of apical caspases. J. Biol. Chem., 276, 34743-34752.
30. HERNANDEZ, M., DE ARRIBA, A.F., MERLOS, M., FUENTES, L., CRESPO, M.S. & NIETO, M.L. (2001). Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappaB-dependent transcription in human astrocytoma cells. Br. J. Pharmacol., 132, 547-555.
31. HOLLOPETER, G., JANTZEN, H.-M., VINCENT, D., LI, G., ENGLAND, L., RAMAKRISHNAN, V., YANG, R.-B., NUDEN, P., JULIUS, D. & CONLEY, P.B. (2001). Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (Lond.), 409, 202-207.
32. HU, Y., FISETTE, P.L., DENLINGER, L.C., GUADARRAMA, A.G., SOMMER, J.A., PROCTOR, R.A. & BERTICS, P.J. (1998). Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J. Biol. Chem., 273, 27170-27175.
33. 7 nucleotide receptor: high selectivity for the human versus rat receptors. Mol. Pharmacol., 54, 22-32.
34. JACOBSON, K.A., JARVIS, M.F. & WILLIAMS, M. (2002). Purine and pyrimidine (P2) receptors as drug targets. J. Med. Chem., 45, 4057-4093.
35. JIN, J., DASARI, V.R., SISTARE, F.D. & KUNAPULI, S.P. (1998). Distribution of P2Y receptor subtypes on haematopoietic Cells. Br. J. Pharmacol., 123, 789-794.
36. JOHN, G.R., SIMPSON, J.E., WOODROOFE, M.N., LEE, S.C. & BROSNAN, C.F. (2001). Extracellular nucleotides differentially regulate interleukin-1β signaling in primary human astrocytes: implications for inflammatory gene expression. J. Neurosci., 21, 4134-4142.
37. JOSEPH, S.M., BUCHAKJIAN, M.R. & DUBYAK, G.R. (2003). Colocalization of ATP release sites and ecto-ATPase activity at the extracellular surface of human astrocytes. J. Biol. Chem., 278, 23331-23342.
38. 7 receptor signalling complex. EMBO J., 20, 6347-6358.
39. KOCHETKOV, S.N., BULARGINA, T.V., SASHCHENKO, L.P. & SEVERIN, E.S. (1977). Studies on the mechanism of action of histone kinase dependent on adenosine 3′:5′-monophosphate. Evidence for involvement of histidine and lysine residues in the phosphotransferase reaction. Eur. J. Biochem., 81, 111-118.
40. 2 purinoceptor-mediated responses. Eur. J. Pharmacol., 217, 217-219.
41. LAMMAS, D.A., STOBER, C., HARVEY, C.J., KENDRICK, N., PANCHALINGAM, S. & KUMARARATNE, D.S. (1997). ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity, 7, 433-444.
42. LAZAROWSKI, E.R., BOUCHER, R.C. & HARDEN, T.K. (2000). Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J. Biol. Chem., 275, 31061-31068.
43. LELAND, P., OBIRI, N., AGGARWAL, B.B. & PURI, R.K. (1995). Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response. Oncol. Res., 7, 227-235.
44. LIU, J.S.H., JOHN, G.R., SIKORA, A., LEE, S.C. & BROSNAN, C.F. (2000). Modulation of interleukin-1β and tumor necrosis factor α signaling by P2 purinergic receptors in human fetal astrocytes. J. Neurosci., 20, 5292-5299.
45. LOWE, P.N. & BEECHEY, R.B. (1982). Interactions between the mitochondrial adenosine triphosphatase and periodate-oxidized adenosine 5′-triphosphate, an affinity label for adenosine 5′-triphosphate binding sites. Biochemistry, 21, 4073-4082.
46. MEANS, T.K., GOLENBOCK, D.T. & FENTON, M.J. (2000). The biology of Toll-like receptors. Cytokine Growth Factor Rev., 11, 219-232.
47. MEHTA, V.B., HART, J. & WEWERS, M.D. (2001). ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J. Biol. Chem., 276, 3820-3826.
48. 2+-ATPase from sarcoplasmic reticulum by periodate oxidized ATP. Biochim. Biophys. Acta, 1039, 305-312.
49. MILLS, G.B., ZHANG, N., MAY, C., HILL, M. & CHUNG, A. (1990). Suramin prevents binding of interleukin-2 to its cell surface receptor: a possible mechanism for immunosuppression. Cancer Res., 50, 3036-3042.
50. MOYNAGH, P.N., WILLIAMS, D.C. & O'NEILL, L.A. (1994). Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. J. Immunol., 153, 2681-2690.
51. 2Z receptor. J. Biol. Chem., 268, 8199-8203.
52. 1 receptor antagonists and partial agonists. J. Med. Chem., 42, 1625-1638.
53. NORTH, R.A. (2002). Molecular physiology of P2X receptors. Physiol. Rev., 82, 1013-1067.
54. PARR, C.E., SULLIVAN, D.M., PARADISO, A.M., LAZAROWSKI, E.R., BURCH, L.H., OLSEN, J.C., ERB, L., WEISMAN, G.A., BOUCHER, R.C. & TURNER, J.T. (1994). Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. U.S.A., 91, 3275-3279.
55. PLESNER, L. (1995). Ecto-ATPases: identities and functions. Int. Rev. Cytol., 158, 141-214.
56. RALEVIC, V. (2000). Roles of purines and pyrimidines in endothelium. In: Handbook of Experimental Pharmacology. eds. Abbracchio, M.B. & Williams, M. Vol. 151/II, pp. 101-120. Berlin: Springer-Verlag.
57. SCHACHTER, J.B., LI, Q., BOYER, J.L., NICHOLAS, R.A. & HARDEN, T.K. (1996). Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br. J. Pharmacol., 118, 167-173.
58. 2 receptors. Neuropharmacology, 36, 1181-1187.
59. 7- independent mechanism. J. Immunol., 163, 558-561.
60. SPERLÁGH, B., HASKÓ, G., NÉMETH, Z. & VIZI, E.S. (1998). ATP released by LPS increases nitric oxide production in RAW 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem. Int., 33, 209-215.
61. STRASSMANN, G., D'ALESSANDRO, F., FONG, M., NORDAN, R.P., NICKEL, P. & CHIZZONITE, R. (1994). Suramin blocks the binding of interleukin-1 to its receptor and neutralizes IL-1 biological activities. Int. J. Immunopharmacol., 11, 931-939.
62. TAYLOR, A.L., KUDLOW, B.A., MARRS, K.L., GREUNERT, D.C., GUGGINO, W.B. & SCHWIEBERT, E.M. (1998). Bioluminescence detection of ATP release mechanisms in epithelia. Am. J. Physiol. Cell Physiol., 275, C1391-C1406.
63. TENNETI, L., GIBBONS, S.J. & TALAMO, B.R. (1998). Expression and trans-synaptic regulation of P2x4 and P2z receptors for extracellular ATP in parotid acinar cells. Effects of parasympathetic denervation. J. Biol. Chem., 273, 26799-26808.
64. VISENTIN, S., RENZI, M., FRANK, C., GRECO, A. & LEVI, G. (1999). Two different ionotropic receptors activated by ATP in rat microglia. J. Physiol., 519, 723-736.
65. WANG, Q., DZIARSKI, R., KIRSCHNING, C.J., MUZIO, M. & GUPTA, D. (2001). Micrococci and peptidoglycan activate TLR2→ MyD88→IRAK→ TRAF→NIK→IKK→NF-kappaB signal transduction pathway that induces transcription of interleukin-8. Infect. Immun., 69, 2270-2276.
66. WANG, L., KARLSSON, L., MOSES, S., HULTGARDH-NILSSON, A., ANDERSSON, M., BORNA, C., GUDBJARTSSON, T., JERN, S. & ERLINGE, D. (2002). P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J. Cardiovasc. Pharmacol., 40, 841-853.
67. WARNY, M., ABOUDOLA, S., ROBSON, S.C., SEVIGNY, J., COMMUNI, D., SOLTOFF, S.P. & KELLY, C.P. (2001). P2Y6 nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J. Biol. Chem., 276, 26051-26056.
68. WESTCOTT, K.R., OLWIN, B.B. & STORM, D.R. (1980). Inhibition of adenylate cyclase by the 2′,3′-dialdehyde of adenosine triphosphate. J. Biol. Chem., 255, 8767-8771.
69. ZHAO, B., BOWDEN, R.A., STAVCHANSKY, S.A. & BOWMAN, P.D. (2001). Human endothelial cell response to Gram-negative lipopolysaccharide assessed with cDNA microarrays. Am. J. Physiol. Cell Physiol., 281, C1587-C1595.
70. ZIMMERMANN, H. (2000). Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg's Arch. Pharmacol., 362, 299-309.